Name: Can-Fite BioPharma
Address: 10 Bareket Street, Petah-Tikva, 49170, ISRAEL
Telephone: +972-3-9241114

Filing Type:

Year:

Date	Form	Description	Pages
04/12/19	SC 13G	Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions	9
04/11/19	D	Official notice of an offering of securities that is made without registration under the Securities Act in reliance on an exemption provided by Regulation D and Section 4(a)(5) under the Act.	6
04/10/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	6
04/04/19	424B5	Prospectus filed pursuant to Rule 424(b)(5)	53
04/04/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-5.1 EX-10.1 EX-10.2	51
04/02/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	6
04/02/19	20-F/A	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	193
03/29/19	20-F	Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) Documents expand_more EX-12.1 EX-12.2 EX-13.1 EX-13.2 EX-15.1	192
03/28/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	10
03/26/19	6-K	Current report of foreign issuer pursuant to Rules 13a-16 and 15d-16 Amendments Documents expand_more EX-99.1	7